Literature DB >> 19571791

The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification.

Daniel C Cattran, Rosanna Coppo, H Terence Cook, John Feehally, Ian S D Roberts, Stéphan Troyanov, Charles E Alpers, Alessandro Amore, Jonathan Barratt, Francois Berthoux, Stephen Bonsib, Jan A Bruijn, Vivette D'Agati, Giuseppe D'Amico, Steven Emancipator, Francesco Emma, Franco Ferrario, Fernando C Fervenza, Sandrine Florquin, Agnes Fogo, Colin C Geddes, Hermann-Josef Groene, Mark Haas, Andrew M Herzenberg, Prue A Hill, Ronald J Hogg, Stephen I Hsu, J Charles Jennette, Kensuke Joh, Bruce A Julian, Tetsuya Kawamura, Fernand M Lai, Chi Bon Leung, Lei-Shi Li, Philip K T Li, Zhi-Hong Liu, Bruce Mackinnon, Sergio Mezzano, F Paolo Schena, Yasuhiko Tomino, Patrick D Walker, Haiyan Wang, Jan J Weening, Nori Yoshikawa, Hong Zhang.   

Abstract

IgA nephropathy is the most common glomerular disease worldwide, yet there is no international consensus for its pathological or clinical classification. Here a new classification for IgA nephropathy is presented by an international consensus working group. The goal of this new system was to identify specific pathological features that more accurately predict risk of progression of renal disease in IgA nephropathy, thus enabling both clinicians and pathologists to improve individual patient prognostication. In a retrospective analysis, sequential clinical data were obtained on 265 adults and children with IgA nephropathy who were followed for a median of 5 years. Renal biopsies from all patients were scored by pathologists blinded to the clinical data for pathological variables identified as reproducible by an iterative process. Four of these variables: (1) the mesangial hypercellularity score, (2) segmental glomerulosclerosis, (3) endocapillary hypercellularity, and (4) tubular atrophy/interstitial fibrosis were subsequently shown to have independent value in predicting renal outcome. These specific pathological features withstood rigorous statistical analysis even after taking into account all clinical indicators available at the time of biopsy as well as during follow-up. The features have prognostic significance and we recommended they be taken into account for predicting outcome independent of the clinical features both at the time of presentation and during follow-up. The value of crescents was not addressed due to their low prevalence in the enrolled cohort.

Entities:  

Mesh:

Year:  2009        PMID: 19571791     DOI: 10.1038/ki.2009.243

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  412 in total

1.  Pathology: Oxford IgA nephropathy classification: valid for children?

Authors:  Ryohei Yamamoto; Yasuyuki Nagasawa
Journal:  Nat Rev Nephrol       Date:  2010-11       Impact factor: 28.314

2.  Urinary mannose-binding lectin is a biomarker for predicting the progression of immunoglobulin (Ig)A nephropathy.

Authors:  L-L Liu; Y Jiang; L-N Wang; N Liu
Journal:  Clin Exp Immunol       Date:  2012-08       Impact factor: 4.330

3.  Mayo Clinic/Renal Pathology Society Consensus Report on Pathologic Classification, Diagnosis, and Reporting of GN.

Authors:  Sanjeev Sethi; Mark Haas; Glen S Markowitz; Vivette D D'Agati; Helmut G Rennke; J Charles Jennette; Ingeborg M Bajema; Charles E Alpers; Anthony Chang; Lynn D Cornell; Fernando G Cosio; Agnes B Fogo; Richard J Glassock; Sundaram Hariharan; Neeraja Kambham; Donna J Lager; Nelson Leung; Michael Mengel; Karl A Nath; Ian S Roberts; Brad H Rovin; Surya V Seshan; Richard J H Smith; Patrick D Walker; Christopher G Winearls; Gerald B Appel; Mariam P Alexander; Daniel C Cattran; Carmen Avila Casado; H Terence Cook; An S De Vriese; Jai Radhakrishnan; Lorraine C Racusen; Pierre Ronco; Fernando C Fervenza
Journal:  J Am Soc Nephrol       Date:  2015-11-13       Impact factor: 10.121

4.  Prognostic value of endocapillary hypercellularity in IgA nephropathy patients with no immunosuppression.

Authors:  Aron Chakera; Clare MacEwen; Shubha S Bellur; La-Or Chompuk; Daniel Lunn; Ian S D Roberts
Journal:  J Nephrol       Date:  2015-08-30       Impact factor: 3.902

5.  Pitfalls in recommending evidence-based guidelines for a protean disease like Henoch-Schönlein purpura nephritis.

Authors:  Jean-Claude Davin; Rosanna Coppo
Journal:  Pediatr Nephrol       Date:  2013-07-09       Impact factor: 3.714

6.  Distribution of Streptococcus mutans strains with collagen-binding proteins in the oral cavity of IgA nephropathy patients.

Authors:  Taro Misaki; Shuhei Naka; Keiko Kuroda; Ryota Nomura; Tempei Shiooka; Yoshitaka Naito; Yumiko Suzuki; Hideo Yasuda; Taisuke Isozaki; Kazuhiko Nakano
Journal:  Clin Exp Nephrol       Date:  2014-12-10       Impact factor: 2.801

7.  Risk factors for persistent proteinuria after a 2-year combination therapy for severe childhood IgA nephropathy.

Authors:  Koichi Kamei; Koichi Nakanishi; Shuichi Ito; Kenji Ishikura; Hiroshi Hataya; Masataka Honda; Kandai Nozu; Kazumoto Iijima; Yuko Shima; Norishige Yoshikawa
Journal:  Pediatr Nephrol       Date:  2014-12-10       Impact factor: 3.714

8.  Histopathologic features aid in predicting risk for progression of IgA nephropathy.

Authors:  Michael Walsh; Aylin Sar; Diane Lee; Serdar Yilmaz; Hallgrimur Benediktsson; Braden Manns; Brenda Hemmelgarn
Journal:  Clin J Am Soc Nephrol       Date:  2010-01-14       Impact factor: 8.237

9.  Urinary Fibrinogen as a Predictor of Progression of CKD.

Authors:  Hongtian Wang; Chunxia Zheng; Yinghui Lu; Qi Jiang; Ru Yin; Ping Zhu; Minlin Zhou; Zhihong Liu
Journal:  Clin J Am Soc Nephrol       Date:  2017-09-13       Impact factor: 8.237

10.  Clinical and pathological features of immunoglobulin A nephropathy patients with nephrotic syndrome.

Authors:  Xin Han; Yi Xiao; Yi Tang; Xiaonan Zheng; Mawluda Anwar; Wei Qin
Journal:  Clin Exp Med       Date:  2019-09-21       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.